An overview of principles of effective treatment of substance use disorders and their potential application to pregnant cigarette smokers

Drug and Alcohol Dependence

Volumn 104, Issue SUPPL. 1, 2009, Pages

  Heil, Sarah H ^a,b   Linares Scott, Teresa ^a   Higgins, Stephen T ^a,b  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

Empirically validated; Pregnant women; Smoking cessation; Substance use disorders; Treatment

Indexed keywords

AMFEBUTAMONE; BUPRENORPHINE; DISULFIRAM; METHADONE; NALTREXONE; PLACEBO; VARENICLINE;

ALCOHOLISM; CIGARETTE SMOKING; CLINICAL TRIAL; DEMOGRAPHY; DRUG DEPENDENCE; HUMAN; INFANT MORTALITY; MORBIDITY; PATIENT COUNSELING; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; REVIEW; SMOKING CESSATION; SOCIAL ASPECT; SOCIAL STATUS; SUBSTANCE ABUSE; TOBACCO DEPENDENCE;

FEMALE; HUMANS; PREGNANCY; SMOKING; SMOKING CESSATION; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 68849117021     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2009.05.012     Document Type: Review

References (92)

1. Anon. Drug Alcohol Depend. 88 Suppl. 2 (2007) 647-651 (special issue on this topic)
2. Ardila A., Rosselli M., and Strumwasser S. Neuropsychological deficits in chronic cocaine abusers. Int. J. Neurosci. 57 (1991) 73-79
3. Ball J.C., and Ross A. The Effectiveness of Methadone Maintenance Treatment (1991), Springer-Verlag, New York
4. Beatty W.W., Katzung V.M., Moreland V.J., and Nixon S.J. Neuropsychological performance of recently abstinence alcoholics and cocaine abusers. Drug Alcohol Depend. 37 (1995) 247-253
5. Belizan J.M., Barros F., Langer A., Farnot U., Victoria C., Villar J., and the Latin American Network for Perinatal and Reproductive Research. Impact of health education during pregnancy on behavior and utilization of health resources. Am. J. Obstet. Gynecol. 173 (1995) 894-899
6. Carise D., Gurel O., McLellan A.T., Dugosh K., and Kendig C. Getting patients the services they need using a computer-assisted system for patient assessment and referral-CASPAR. Drug Alcohol Depend. 80 (2005) 177-189
7. Carroll K.M., and Onken L.S. Behavioral therapies for drug abuse. Am. J. Psychiatry 162 (2005) 1452-1460
8. Carroll K.M., Rounsaville B.J., and Gawin F.H. A comparative trial of psychotherapies for ambulatory cocaine abusers: relapse prevention and interpersonal psychotherapy. Am. J. Drug Alcohol Abuse 17 (1991) 229-247
9. Chermack S.T., Roll J., Reilly M., Davis L., Kilaru U., and Grabowski J. Comparison of patient self-reports and urinalysis results obtained under naturalistic methadone treatment conditions. Drug Alcohol Depend. 59 (2000) 43-49
10. Cnattingius S. The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine Tob. Res. 6 (2004) S125-S140
11. Condelli W.S., and Hubbard R.L. Relationship between time spent in treatment and client outcomes from therapeutic communities. J. Subst. Abuse Treat. 11 (1994) 25-33
12. Del Boca F.K., and Noll J.A. Truth or consequences: the validity of self-report data in health services research on addictions. Addiction 95 (2000) S347-S360
13. Dempsey D., Jacob P., and Benowitz N.L. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J. Pharmacol. Exp. Ther. 301 (2002) 594-598
14. Donatelle R.J., Prows S.L., Champeau D., and Hudson D. Randomised controlled trial using social support and financial incentives for high risk pregnant smokers: significant other supporter (SOS) program. Tob. Control 9 (2000) iii67-iii69
15. Dunn K.E., Sigmon S.C., McGee M.R., Heil S.H., and Higgins S.T. Evaluation of ongoing oxycodone abuse among methadone-maintained patients. J. Subst. Abuse Treat. 35 (2008) 451-456
16. Dutra L., Stathopoulou G., Basden S.L., Leyro T.M., Powers M.B., and Otto M.W. A meta-analytic review of psychosocial interventions for substance use disorders. Am. J. Psychiatry 165 (2008) 179-187
17. Ebrahim S.H., Decoufle P., and Palakathodi A.S. Combined tobacco and alcohol use by pregnant and reproductive-aged women in the United States. Obstet. Gynecol. 96 (2000) 767-771
18. Ershoff D.H., Hall Ashford T., and Goldenberg R.L. Helping pregnant women quit smoking: an overview. Nicotine Tob. Res. 6 (2004) S101-S105
19. Festinger D.S., Lamb R.J., Kountz M.R., Kirby K.C., and Marlowe D. Pretreatment dropout as a function of treatment delay and client variables. Addict Behav. 20 (1995) 111-115
20. Festinger D.S., Lamb R.J., Marlowe D.B., and Kirby K.C. From telephone to office: intake attendance as a function of appointment delay. Addict Behav. 20 (2002) 111-115
21. Fingerhut L.A., Kleinman J.C., and Kendrick J.S. Smoking before, during, and after pregnancy. Am. J. Public Health 80 (1990) 541-544
22. Fiore M.C., Jaen C.R., Baker T.B., Bailey W.C., Benowitz N.L., Curry S.J., et al. Treating Tobacco Use and Dependence: 2008 Update (2008), U.S. Department of Health and Human Services, Public Health Service, Rockville, MD 257
23. Fish L.J., Peterson B.L., Namenek Brower R.J., Lyna P., Oncken C.A., Swamy G.K., Myers E.R., Pletsch P.K., and Pollak K.I. Adherence to nicotine replacement therapy among pregnant smokers. Nicotine Tob. Res. 11 (2009) 514-518
24. Garavan H., and Hester R. The role of cognitive control in cocaine dependence. Neuropsychol. Rev. 17 (2007) 337-345
25. Hanna E.Z., Faden V.B., and Dufour M.C. The motivational correlates of drinking, smoking, and illicit drug use during pregnancy. J. Subst. Abuse 6 (1994) 155-167
26. Hasin D., Liu X., Nunes E., McCloud S., Samet S., and Endicott J. Effects of major depression on remission and relapse of substance dependence. Arch. Gen. Psychiatry 59 (2002) 375-380
27. Haynes R.B. Determinants of compliance: the disease and the mechanics of treatment. In: Haynes R.B., Taylor D.W., and Sackett D.L. (Eds). Compliance in Health Care (1979), Johns Hopkins University Press, Baltimore 49-62
28. Haynes R.B., and Dantes R. Patient compliance in the design and interpretation of clinical trials. Control Clin. Trials 8 (1987) 12-19
29. Heil S.H., Higgins S.T., Bernstein I.M., Solomon L.J., Thomas C.S., Badger G.J., and Lynch M.E. Effects of voucher-based incentives on abstinence from cigarette smoking and fetal growth among pregnant women. Addiction 109 (2008) 1009-1018
30. Hesse M. Integrated psychological treatment for substance use and co-morbid anxiety or depression vs. treatment for substance use alone. A systematic review of the published literature. BMC Psychiatry 9 (2009) 6
31. Hester R., and Garavan H. Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulated and cerebellar activity. J. Neurosci. 24 (2004) 11017-11022
32. Higgins S.T., Badger G.J., and Budney A.J. Initial abstinence and success in achieving longer term cocaine abstinence. Exp. Clin. Psychopharmacol. 8 (2000) 377-386
33. Higgins S.T., Heil S.H., Badger G.J., Mongeon J.A., Solomon L.J., McHale L., and Bernstein I.M. Biochemical verification of smoking status in pregnant and recently postpartum women. Exp. Clin. Psychopharmacol. 15 (2007) 58-66
34. Higgins S.T., Heil S.H., Badger G.J., Skelly J.M., Solomon L.J., and Bernstein I.M. Educational disadvantage and cigarette smoking during pregnancy. Drug Alcohol Depend. 104 Suppl 1 (2009) S100-S105
35. Higgins S.T., Heil S.H., Dumeer A.M., Thomas C.S., Solomon L.J., and Bernstein I.M. Smoking status in the initial weeks of quitting as a predictor of smoking-cessation outcomes in pregnant smokers. Drug Alcohol Depend. 85 (2006) 138-141
36. Higgins S.T., Heil S.H., Rogers R.E., and Chivers L. Cocaine. In: Higgins S.T., Silverman K., and Heil S.H. (Eds). Contingency Management in the Treatment of Substance Use Disorders: A Science-based Treatment Innovation (2008), Guilford Press, New York 19-41
37. Higgins S.T., Heil S.H., Solomon L.J., Bernstein I.M., Lussier J.P., Abel R.L., Lynch M.E., and Badger G.J. A pilot study on voucher-based incentives to promote abstinence from cigarettes smoking during pregnancy and post-partum. Nicotine Tob. Res. 6 (2004) 1015-1020
38. Higgins, S.T., Heil, S.H., Solomon, L.J., Bernstein, I.M., Rogers, R., in press. Contingency management to promote smoking cessation among pregnant women. Nicotine Tob Res.
39. Hoffman K.A., Ford J.H., Choi D., Gustafson D.H., and McCarty D. Replication and sustainability of improved access and retention with the Network for the Improvement of Addiction Treatment. Drug Alcohol Depend. 98 (2008) 63-69
40. Hser Y.I., Polinsky M.L., Maglione M., and Anglin M.D. Matching clients' needs with drug treatment services. J. Subst. Abuse Treat. 16 (1999) 299-305
41. Hughes J.C., and Cook C.C. The efficacy of disulfiram: a review of outcome studies. Addiction 92 (1997) 381-395
42. Huisman M., Kunst A.E., and Mackenbach J.P. Intelligence and socioeconomic inequalities in health. Lancet 366 (2005) 807-808
43. Jane-Llopis E., and Matytsina I. Mental health and alcohol, drugs and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs. Drug Alcohol Rev. 25 (2006) 515-536
44. Keller M.B. The persistent risk of chronicity in recurrent episodes of nonbipolar major depressive disorder: a prospective follow-up. Am. J. Psychiatry 143 (1986) 24-28
45. Kenford S.L., Fiore M.C., Jorenby D.E., Smith S.S., Wetter D., and Baker T.B. Predicting smoking cessation: who will quit with and without the nicotine patch. JAMA 271 (1994) 589-594
46. Kramer M.S., Sequin L., Lydon J., and Goulet L. Socio-economic disparities in pregnancy outcomes: why do the poor fare so poorly?. Paediatr. Perinat. Epidemiol. 14 (2000) 194-210
47. Krystal J.H., Cramer J.A., Krol W.F., Kirk G.F., Rosenheck R.A., and Veterans Affairs Naltrexone Cooperative Study 425 Group. Naltrexone in the treatment of alcohol dependence. N. Engl. J. Med. 345 (2001) 1734-1739
48. Lieberman E., Gremy I., Lang J.M., and Cohen A.P. Low birthweight at term and the timing of fetal exposure to maternal smoking. Am. J. Public Health 84 (1994) 1127-1131
49. Linares Scott T., Heil S.H., Higgins S.T., Badger G.J., and Bernstein I.M. Depressive symptoms predict smoking status among pregnant women. Addict. Behav. 34 (2009) 705-708
50. Ludman E.J., McBride C.M., Nelson J.C., Curry S.J., Grothaus L.C., Lando H.A., and Pirie P.L. Stress, depressive symptoms, and smoking cessation among pregnant women. Health Psychol. 19 (2000) 21-27
51. Lumley J., Oliver S.S., Chamberlain C., and Oakley L. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst. Rev. 4 (2004) 1-88
52. MacArthur C., and Knox E.G. Smoking in pregnancy: effects of stopping at different stages. Br. J. Obstet. Gynaecol. 95 (1988) 551-555
53. Mathews T.J. Smoking during pregnancy, 1990-96. Natl. Vital Stat. Rep. 47 (1998) 1-12
54. Mattick R.P., Kimber J., Breen C., and Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst. Rev. 16 (2008) CD002207
55. McLellan A.T., Alterman A.I., Cacciola J., Metzger D., and O'Brien C.P. A new measure of substance abuse treatment: initial studies of the treatment services review. J. Nerv. Ment. Dis. 180 (1992) 101-110
56. McLellan A.T., Arndt I.O., Metzger D.S., Woody G.E., and O'Brien C.P. The effects of psychosocial services in substance abuse treatment. JAMA 269 (1993) 1953-1959
57. McLellan A.T., Grissom G.R., Zanis D., Randall M., Brill P., and O'Brien C.P. Problem-service 'matching' in addiction treatment: a prospective study in four programs. Arch. Gen. Psychiatry 54 (1997) 730-735
58. Melvin C.L., and Gaffney C.A. Treating nicotine use and dependence of pregnant and parenting smokers: an update. Nicotine Tob. Res. 6 (2004) S107-S124
59. Mullen P.D. How can more smoking suspension during pregnancy become lifelong abstinence? Lessons learned about predictors, interventions, and gaps in our accumulated knowledge. Nicotine Tob. Res. 6 (2004) S217-S238
60. Mullen P.D., Carbonari J.P., Tabak E.R., and Glenday M.C. Improving disclosure of smoking by pregnant women. Am. J. Obstet. Gynecol. 165 (1991) 409-413
61. Nace E.P., Birkmayer F., Sullivan M.A., Galanter M., Fromson J.A., Frances R.J., Levin F.R., Lewis C., Suchinsky R.T., Tamerin J.S., and Westermeyer J. Socially sanctioned coercion mechanisms for addiction treatment. Am. J. Addict. 16 (2007) 15-23
62. National Institute on Drug Abuse. Principles of Drug Addiction Treatment: A Research-based Guide. 2nd ed. (2009), National Institutes of Health, Rockville, MD
63. Orleans C.T., Barker D.C., Kaufman N.J., and Marx J.F. Helping pregnant smokers quit: meeting the challenge in the next decade. Tob. Control. 9 (2000) iii6-iii11
64. Poland M.L., Dombrowski M.P., Ager J.W., and Sokol R.J. Punishing pregnant drug users: enhancing the flight from care. Drug Alcohol Depend. 31 (1993) 199-203
65. Pollak K.I., Oncken C.A., Lipkus I.M., Lyna P., Swamy G.K., Pletsch P.K., Peterson B.L., Heine R.P., Brouwer R.J., Fish L., and Myers E.R. Nicotine replacement and behavioral therapy for smoking cessation in pregnancy. Am. J. Prev. Med. 33 (2007) 297-305
66. Preston K.L., Silverman K., Higgins S.T., Brooner R.K., Montoya I., Schuster C.R., and Cone E.J. Cocaine use early in treatment predicts outcome in a behavioral treatment program. J. Consult. Clin. Psychol. 66 (1998) 691-696
67. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: project MATCH posttreatment drinking outcomes. J. Stud. Alcohol 58 (1997) 7-29
68. Ruger J.P., Weinstein M.C., Hammond S.K., Kearney M.H., and Emmons K.M. Cost-effectiveness of motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women: a randomized controlled trial. Val. Health. 11 (2008) 191-198
69. Russell T., Crawford M., and Woodby L. Measurements for active cigarette smoke exposure in prevalence and cessation studies: why simply asking pregnant women isn't enough. Nicotine Tob. Res. 6 (2004) S141-S151
70. Sexton M., and Hebel J.R. A clinical trial of change in maternal smoking and its effect on birth weight. JAMA 251 (1984) 911-915
71. Sherman M.F., and Bigelow G.E. Validity of patients' self-reported drug use as a function of treatment status. Drug Alcohol Depend. 30 (1992) 1-11
72. Shiffman S., and Sweeney C.T. Ten years after the Rx-to-OTC switch of nicotine replacement therapy: what have we learned about the benefits and risks of non-prescription availability?. Health Policy 86 (2008) 17-26
73. Silverman K., Chutuape M.A., Bigelow G.E., and Stitzer M.L. Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: effects of reinforcement magnitude. Psychopharmacology (Berl.) 146 (1999) 128-138
74. Simpson D.D. National treatment system evaluation based on the Drug Abuse Reporting Program (DARP) followup research. NIDA Res. Monogr. 51 (1984) 29-41
75. Simpson D.D., Joe G.W., Rowan-Szal G.A., and Greener J.M. Drug abuse treatment process components that improve retention. J. Subst. Abuse Treat. 14 (1997) 565-572
76. Slotkin T.A. Fetal nicotine or cocaine exposure: which one is worse. J. Pharmacol. Exp. Ther. 285 (1998) 931-945
77. Slotkin T.A. If nicotine is a developmental neurotoxicant in animal studies, dare we recommend nicotine replacement therapy in pregnant women and adolescents?. Neurotoxicol. Teratol. 30 (2008) 1-19
78. Solomon L.J., and Quinn V.P. Spontaneous quitting: self-initiated smoking cessation in early pregnancy. Nicotine Tob. Res. 6 (2004) S203-S216
79. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob. Res. 4 (2002) 149-159
80. Stark M.J., Campbell B.K., and Brinkerhoff C.V. "Hello, may we help you?" A study of attrition prevention at the time of the first phone contact with substance-abusing clients. Am. J. Drug Alcohol Abuse 16 (1990) 67-76
81. Steenland K., Henley J., and Thun M. All-cause and cause-specific death rates by educational status for two million people in two American Cancer Society cohorts, 1959-1996. Am. J. Epidemiol. 156 (2002) 11-21
82. Steenland K., Rodriguez C., Mondul A., Calle E.E., and Thun M. Prostate cancer incidence and survival in relation to education (United States). Cancer Causes Control 15 (2004) 939-945
83. Substance Abuse and Mental Health Services Administration, Office of Applied Studies, 2006. National Survey of Substance Abuse Treatment Services (N-SSATS). Data on Substance Abuse Treatment Facilities. DASIS Series: S-39, DHHS Publication No. (SMA) 07-4296, Rockville, MD.
84. Substance Abuse and Mental Health Services Administration, Office of Applied Studies, 2008. Results from the 2007 National Survey on Drug Use and Health: National Findings (NSDUH Series H-34, DHHS Publication No. SMA 08-4343). Rockville, MD.
85. The American College of Obstetricians and Gynecologists. Guidelines for diagnostic imaging during pregnancy. Obstet. Gynecol. 104 (2004) 647-651
86. U.S. Department of Health and Human Services, 2001. Women and smoking: A report of the Surgeon General. U.S. Department of Health and Human Services, Public Health Service, Office of the Surgeon General, Rockville, MD.
87. U.S. General Accounting Office, 1990. Drug exposed infants: A generation at risk: Report to the Chairman, Committee on Finance, U.S. Senate. Washington, DC: General Accounting Office.
88. Volkow N.D., Fowler J.S., Wang G.J., and Swanson J.M. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol. Psychiatry 9 (2004) 557-569
89. Volkow N.D., Fowler J.S., Wang G.J., Swanson J.M., and Telang F. Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch. Neurol. 64 (2007) 1575-1579
90. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Gatley S.J., Hitzemann R., Chen A.D., Dewey S.L., and Pappas N. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 386 (1997) 830-833
91. Walker R. Retention in treatment-indicator or illusion. Subst. Use Misuse 44 (2009) 18-27
92. Wisborg K., Henriksen T.B., Jesperson L.B., and Secher N.J. Nicotine patches for pregnant smokers: a randomized controlled study. Obstet. Gynecol. 96 (2000) 967-971